ethinyl estradiol has been researched along with Cancer of Endometrium in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Feng, Y; Li, X; Liu, Y; Wang, Y; Yao, D; Zhang, F | 1 |
| Burchardt, NA; Fortner, RT; Kaaks, R; Shafrir, AL; Tworoger, SS | 1 |
| Benjamin, E; Conway, GS; McGregor, D; Olaitan, A; Saridogan, E; Swamy, A | 1 |
| Merz, WE | 1 |
| Botella, J; Delansorne, R; Duc, I; Duranti, E; Paris, J; Viader, V | 1 |
| Denis, C | 1 |
| Elstein, M | 1 |
| Back, DJ; Rudland, PS; Wild, MJ | 1 |
| Kaunitz, AM | 1 |
| Falany, CN; Falany, JL; Kotov, A; Wang, J | 1 |
| Aoki, Y; Hirose, M; Mitsumori, K; Nagata, O; Onodera, H; Shimo, T; Takagi, H; Tamura, T; Yasuhara, K | 1 |
| Diel, P; Laudenbach-Leschowski, U; Michna, H; Schulz, T; Smolnikar, K; Vollmer, G | 1 |
2 review(s) available for ethinyl estradiol and Cancer of Endometrium
| Article | Year |
|---|---|
[Estrogen-progestin contraception. Disadvantages of estrogen reduction].
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral, Combined; Endometrial Neoplasms; Ethinyl Estradiol; Female; Fibrocystic Breast Disease; Humans; Incidence; Luteinizing Hormone; Ovarian Cysts; Ovarian Neoplasms; Progestins; Risk Factors; Time Factors; Uterine Hemorrhage | 1993 |
Oral contraceptive health benefits: perception versus reality.
Topics: Acne Vulgaris; Anemia; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Dysmenorrhea; Endometrial Neoplasms; Ethinyl Estradiol; Female; Humans; Osteoporosis; Ovarian Neoplasms; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1999 |
10 other study(ies) available for ethinyl estradiol and Cancer of Endometrium
| Article | Year |
|---|---|
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
Topics: Androgen Antagonists; Animals; Apoptosis; Autophagy; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Endometrial Neoplasms; Ethinyl Estradiol; Female; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin-Like Growth Factor I; Metformin; Mice; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.
Topics: Adult; Aged; Cohort Studies; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Estrogens; Ethinyl Estradiol; Female; Humans; Mestranol; Middle Aged; Progestins; Prospective Studies | 2021 |
Endometrial cancer in a woman with 46,XY pure gonadal dysgenesis.
Topics: Adult; Drug Combinations; Endometrial Neoplasms; Ethinyl Estradiol; Female; Gonadal Dysgenesis, 46,XY; Hormone Replacement Therapy; Hormones; Humans; Incidental Findings; Levonorgestrel; Ovariectomy; Treatment Outcome | 2015 |
[Hormone replacement therapy and the risk of developing breast cancer].
Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrial Neoplasms; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment | 2004 |
Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Aminoglutethimide; Aromatase Inhibitors; Binding, Competitive; Cytosol; Endometrial Neoplasms; Endometrium; Enzyme Induction; Enzyme Inhibitors; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Norpregnanes; Norprogesterones; Pregnanes; Progesterone; Progestins; Receptors, Estrogen; Tamoxifen; Testosterone; Tumor Cells, Cultured | 1995 |
Low dose contraceptive formulations: is further reduction in steroid dosage justified?
Topics: Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Ethinyl Estradiol; Female; Humans; Ovarian Neoplasms; Progestins; Thrombosis | 1994 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Cytosol; Diethylstilbestrol; Endometrial Neoplasms; Estrogens; Ethinyl Estradiol; Female; Humans; Kinetics; Receptors, Estrogen; Substrate Specificity; Sulfotransferases; Tumor Cells, Cultured | 1999 |
Modifying effects of ethinylestradiol but not methoxychlor on N-ethyl-N-nitrosourea-induced uterine carcinogenesis in heterozygous p53-deficient CBA mice.
Topics: Adenocarcinoma, Clear Cell; Animals; Body Weight; Carcinogens; Cocarcinogenesis; Diet; Drug Synergism; Endometrial Hyperplasia; Endometrial Neoplasms; Ethinyl Estradiol; Ethylnitrosourea; Female; Genes, p53; Immunoenzyme Techniques; Injections, Intraperitoneal; Methoxychlor; Mice; Mice, Inbred CBA; Mice, Knockout; Organ Size; Proliferating Cell Nuclear Antigen; Sarcoma, Endometrial Stromal; Uterus | 2000 |
Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium.
Topics: Adenocarcinoma; Animals; Clusterin; Complement C3; Endometrial Neoplasms; Epithelium; Estrogens, Non-Steroidal; Ethinyl Estradiol; Female; Gene Expression; Genistein; Glycoproteins; Isoflavones; Molecular Chaperones; Organ Size; Ovariectomy; Phytoestrogens; Plant Preparations; Rats; RNA, Messenger; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured; Uterus; Vagina | 2001 |